Hypertonic saline: a novel therapy for advanced heart failure?

[1]  A. Tuttolomondo,et al.  Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects. , 2003, American heart journal.

[2]  A. Kurtz,et al.  Low tonicity mediates a downregulation of cyclooxygenase-1 expression by furosemide in the rat renal papilla. , 2002, Journal of the American Society of Nephrology : JASN.

[3]  L. Stevenson,et al.  Medical management of advanced heart failure. , 2002, JAMA.

[4]  V. Hasselblad,et al.  Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE): design and rationale. , 2001, American heart journal.

[5]  J. Daubert,et al.  Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. , 2001, The New England journal of medicine.

[6]  S. Kaukinen,et al.  Hypertonic saline (7.5%) after coronary artery bypass grafting , 2001, European journal of anaesthesiology.

[7]  G. Licata,et al.  Effects of high‐dose furosemide and small‐volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure , 2000, European journal of heart failure.

[8]  M. Drazner,et al.  Tailored therapy using dobutamine and nitroglycerin in advanced heart failure. , 1999, The American journal of cardiology.

[9]  E. Vicaut,et al.  Comparison of the acute hemodynamic effects of hypertonic or colloid infusions immediately after mitral valve repair. , 1999, Critical care medicine.

[10]  B. Pitt,et al.  The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. , 1999, The New England journal of medicine.

[11]  Y. Moshkovitz,et al.  Increased toxicity of high‐dose furosemide versus low‐dose dopamine in the treatment of refractory congestive heart failure , 1997, Clinical pharmacology and therapeutics.

[12]  B Schwilk,et al.  Effect of 7.2% Hypertonic Saline/6% Hetastarch on Left Ventricular Contractility in Anesthetized Humans , 1995, Anesthesiology.

[13]  Å. Hjalmarson,et al.  Beta-blocker treatment for chronic heart failure. The frog prince. , 1994, Circulation.

[14]  P. Constable,et al.  Hypertonic saline is a negative inotropic agent in normovolumic dogs. , 1994, The American journal of physiology.

[15]  D. White,et al.  Cardiac contractility and blood flow distribution following resuscitation with 7.5% hypertonic saline in anesthetized dogs. , 1991, Circulatory shock.

[16]  M. Luu,et al.  Importance of hemodynamic response to therapy in predicting survival with ejection fraction ≤ 20% secondary to ischemic or nonischemic dilated cardiomyopathy , 1990 .

[17]  S. Bachmann,et al.  Structural adaptation of the distal convoluted tubule to prolonged furosemide treatment. , 1985, The American journal of physiology.

[18]  I. Velasco,et al.  TREATMENT OF REFRACTORY HYPOVOLÆMIC SHOCK BY 7·5% SODIUM CHLORIDE INJECTIONS , 1980, The Lancet.

[19]  M. Drazner,et al.  Potential contributing factors to noncompliance with dietary sodium restriction in patients with heart failure. , 2002, American heart journal.

[20]  W. Pfaller,et al.  Inhibition of angiotensin-converting enzyme modulates structural and functional adaptation to loop diuretic-induced diuresis. , 1997, Kidney international.